Study of Catheter-Free Intravesical Instillation Using a Special Syringe Adapter for Bladder Conditions in Adults Aged 18 to 80

What this Trial Is About

This research aims to evaluate a catheter-free method for delivering medications directly into the bladder, called intravesical instillation. This method is commonly used for conditions such as interstitial cystitisbladder pain syndrome ICBPS, recurrent urinary tract infections, bladder cancer, and post-chemotherapy or post-radiation cystitis. The study investigates whether this approach reduces discomfort and complications while maintaining treatment effectiveness compared to traditional catheter-based methods. The treatment involves using a specialized urological adapter called UroDapter, which attaches to a syringe and is inserted about 6-8 mm into the urethral opening. This allows medication to reach the bladder without catheterization, aiming to minimize pain, discomfort, and risks like urinary tract infections and urethral damage. Patients receive catheter-free intravesical instillation therapy as their physicians recommend, covering various bladder conditions. Participants will be monitored for up to two weeks to assess patient discomfort during the catheter-free instillation. Researchers will also track success rates of the procedure, incidence of urinary tract infections, urethral bleeding, other complications, and patient preference for this method. Data will be collected anonymously to improve treatment protocols, patient satisfaction, and compliance with intravesical therapies.

Evaluating the Efficacy and Patient Experience of Catheter-Free Intravesical Instillation